<?xml version='1.0' encoding='utf-8'?>
<document id="28734645"><sentence text="Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase."><entity charOffset="50-75" id="DDI-PubMed.28734645.s1.e0" text="valproic acid glucuronide" /><entity charOffset="80-90" id="DDI-PubMed.28734645.s1.e1" text="carbapenem" /><pair ddi="false" e1="DDI-PubMed.28734645.s1.e0" e2="DDI-PubMed.28734645.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28734645.s1.e0" e2="DDI-PubMed.28734645.s1.e1" /></sentence><sentence text="The efficacy of the antiepileptic drug VPA is decreased by co-administered carbapenems (CBPMs)"><entity charOffset="75-86" id="DDI-PubMed.28734645.s2.e0" text="carbapenems" /></sentence><sentence text=" The mechanism of CBPM selective inhibition of acylpeptide hydrolase (APEH) hydrolysis of VPA-glucuronide (VPA-G) to VPA is unclear due to the lack of APEH structural information"><entity charOffset="90-105" id="DDI-PubMed.28734645.s3.e0" text="VPA-glucuronide" /><entity charOffset="107-112" id="DDI-PubMed.28734645.s3.e1" text="VPA-G" /><entity charOffset="117-120" id="DDI-PubMed.28734645.s3.e2" text="VPA" /><pair ddi="false" e1="DDI-PubMed.28734645.s3.e0" e2="DDI-PubMed.28734645.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28734645.s3.e0" e2="DDI-PubMed.28734645.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s3.e0" e2="DDI-PubMed.28734645.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s3.e1" e2="DDI-PubMed.28734645.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s3.e1" e2="DDI-PubMed.28734645.s3.e2" /></sentence><sentence text=" Here we performed homology modeling of the three-dimensional structure of APEH and subsequent docking simulations with a modeled structure to understand this mechanism" /><sentence text=" Docking simulations indicated that four groups of binding structures were involved in the binding of VPA-G, panipenem, and meropenem to APEH, but only one or two binding structures were involved in the binding of meropenem with an open β-lactam ring structure and other antibiotics involving ampicillin"><entity charOffset="124-133" id="DDI-PubMed.28734645.s5.e0" text="meropenem" /><entity charOffset="214-223" id="DDI-PubMed.28734645.s5.e1" text="meropenem" /><entity charOffset="237-245" id="DDI-PubMed.28734645.s5.e2" text="β-lactam" /><entity charOffset="293-303" id="DDI-PubMed.28734645.s5.e3" text="ampicillin" /><entity charOffset="102-111" id="DDI-PubMed.28734645.s5.e4" text="VPA-G" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e4" e2="DDI-PubMed.28734645.s5.e4" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e4" e2="DDI-PubMed.28734645.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e4" e2="DDI-PubMed.28734645.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e4" e2="DDI-PubMed.28734645.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e4" e2="DDI-PubMed.28734645.s5.e3" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e0" e2="DDI-PubMed.28734645.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e0" e2="DDI-PubMed.28734645.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e0" e2="DDI-PubMed.28734645.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e0" e2="DDI-PubMed.28734645.s5.e3" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e1" e2="DDI-PubMed.28734645.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e1" e2="DDI-PubMed.28734645.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e1" e2="DDI-PubMed.28734645.s5.e3" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e2" e2="DDI-PubMed.28734645.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s5.e2" e2="DDI-PubMed.28734645.s5.e3" /></sentence><sentence text=" One of the four VPA-G binding structures was close enough to the APEH catalytic triad to facilitate VPA-G hydrolysis"><entity charOffset="17-21" id="DDI-PubMed.28734645.s6.e0" text="VPA-G" /><entity charOffset="101-105" id="DDI-PubMed.28734645.s6.e1" text="VPA-G" /><pair ddi="false" e1="DDI-PubMed.28734645.s6.e0" e2="DDI-PubMed.28734645.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28734645.s6.e0" e2="DDI-PubMed.28734645.s6.e1" /></sentence><sentence text=" This binding structure was also the most stable binding structure for panipenem, suggesting potential inhibition of VPA-G hydrolysis by panipenem"><entity charOffset="117-121" id="DDI-PubMed.28734645.s7.e0" text="VPA-G" /></sentence><sentence text=" Fragment molecular orbital calculations of interaction energies of amino acid residues of APEH with VPA-G, panipenem, and meropenem indicated that the binding structure for panipenem closest to the catalytic triad is stabilized upon APEH interaction"><entity charOffset="68-78" id="DDI-PubMed.28734645.s8.e0" text="amino acid" /><entity charOffset="101-106" id="DDI-PubMed.28734645.s8.e1" text="VPA-G" /><entity charOffset="108-117" id="DDI-PubMed.28734645.s8.e2" text="panipenem" /><entity charOffset="123-132" id="DDI-PubMed.28734645.s8.e3" text="meropenem" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e0" e2="DDI-PubMed.28734645.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e0" e2="DDI-PubMed.28734645.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e0" e2="DDI-PubMed.28734645.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e0" e2="DDI-PubMed.28734645.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e1" e2="DDI-PubMed.28734645.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e1" e2="DDI-PubMed.28734645.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e1" e2="DDI-PubMed.28734645.s8.e3" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e2" e2="DDI-PubMed.28734645.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28734645.s8.e2" e2="DDI-PubMed.28734645.s8.e3" /></sentence><sentence text=" These data suggest that APEH binding characteristics with CBPMs may help explain the selective inhibition of APEH by CBPMs" /><sentence text="" /></document>